Table 3.
T lymphocyte subsets and NK cells in different stages of gastric cancer (¯x ± s)
| groups | n | CD3+ (%) | CD4+ (%) | CD8+ (%) | CD4+/CD8+ | NK |
| tumor gross type | ||||||
| early | 8 | 57.5 ± 5.5 | 32.1 ± 9.1 | 28.2 ± 10.0 | 1.1 ± 0.6 | 8.7 ± 3.9 |
| advanced | 34 | 52.9 ± 9.8b | 26.8 ± 6.0b | 35.5 ± 8.1 | 0.8 ± 0.3a | 9.6 ± 4.5 |
| lymph node metastasis | ||||||
| without | 13 | 57.3 ± 7.8 | 31.2 ± 7.4 | 32.4 ± 8.5 | 1.1 ± 0.4 | 9.7 ± 4.7 |
| with | 29 | 52.5 ± 10.1c | 25.7 ± 5.8c | 36.7 ± 8.1 | 0.7 ± 0.3c | 9.2 ± 4.3 |
a
P < 0.05,
b
P < 0.01vs early-stage cancer;
c
P < 0.05 vs the cancer patients without lymph node metastasis